Increased IL-37 in Atherosclerotic Disease could be Suppressed by Atorvastatin Therapy
Author:
Affiliation:
1. Department of cardiology; Nanshan Hospital; Guangdong Medical College; Shenzhen China
2. Department of Pathophysiology; School of Medicine; Shenzhen University; Shenzhen China
3. School of Guangdong Medical College; Zhanjiang China
Funder
National Natural Science Foundation of China
Science Foundation of Shenzhen
Publisher
Wiley
Subject
Immunology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/sji.12322/fullpdf
Reference25 articles.
1. Cardiovascular disease in Europe 2014: epidemiological update;Nichols;Eur Heart J,2014
2. The pathogenesis of coronary artery disease and the acute coronary syndromes (2);Fuster;N Engl J Med,1992
3. The pathogenesis of atherosclerosis (first of two parts);Ross;N Engl J Med,1976
4. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy;Hartman;Cardiol Rev,2014
5. The protective effect of interleukin-37 on vascular calcification and atherosclerosis in apolipoprotein E-deficient mice with diabetes;Chai;J Interferon Cytokine Res,2015
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-Inflammatory Effect of Atorvastatin and Rosuvastatin on Monosodium Urate-Induced Inflammation through IL-37/Smad3-Complex Activation in an In Vitro Study Using THP-1 Macrophages;Pharmaceuticals;2024-07-03
2. The effect of lipid-lowering therapies on the pro-inflammatory and anti-inflammatory properties of vascular endothelial cells;PLOS ONE;2023-02-08
3. The emerging role of Interleukin 37 in bone homeostasis and inflammatory bone diseases;International Immunopharmacology;2021-09
4. Pioglitazone combined with atorvastatin promotes plaque stabilization in a rabbit model;Vascular;2021-09-01
5. Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19;Frontiers in Cardiovascular Medicine;2021-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3